Perella Weinberg Partners Capital Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Perella Weinberg Partners Capital Management’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-66,300	Closed	-$1.39M	–	120
2016 Q3	$1.39M	Buy	+66,300	New	+$764K	0.4%	61

Perella Weinberg Partners Capital Management's VTAE Position: Q4 2016 in Review

Perella Weinberg Partners Capital Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 66,300 shares — an estimated $1.39M sold.

Perella Weinberg Partners Capital Management first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $1.39M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Perella Weinberg Partners Capital Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Perella Weinberg Partners Capital Management sold 66,300 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $1.39M.
Perella Weinberg Partners Capital Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
Perella Weinberg Partners Capital Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $1.39M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Perella Weinberg Partners Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.